Results 121 to 130 of about 130,554 (162)

Membranous nephropathy complicated by immune thrombocytopenia treated with low-density lipoprotein apheresis: a case report and literature review. [PDF]

CEN Case Rep, 2022
Nishizawa K, Yamashita T, Ogawa Y, Kobayashi H.   +3 more
europepmc   +1 more source

Efficacy of Low-Density Lipoprotein Apheresis in an Adult Case of Recurrent Focal Segmental Glomerulosclerosis Post-kidney Transplant. [PDF]

Cureus
Javanbakht A, Souter K, Armendariz T, Webb CB.   +3 more
europepmc   +1 more source

Low-density lipoprotein apheresis for recurrent focal segmental glomerulosclerosis in pediatric kidney transplant recipients: a systematic review and meta-analysis. [PDF]

Pediatr Nephrol
Hayes ET, Matossian D, Wescott AB, Verghese PS.   +3 more
europepmc   +1 more source

COVID-19 swab collection and serological screening in lipoprotein apheresis unit. [PDF]

J Clin Apher, 2020
Sbrana F, Dal Pino B, Bigazzi F, Pianelli M, Luciani R, Sampietro T.   +5 more
europepmc   +1 more source

Treating PAD Patients with Lipoprotein Apheresis. [PDF]

J Atheroscler Thromb
Harada-Shiba M.
europepmc   +1 more source

Early low-density lipoprotein apheresis for steroid-resistant minimal change disease with acute kidney injury: a case report. [PDF]

CEN Case Rep
Hiramatsu M, Inoue M, Kamegai N, Michiya O, Yamamoto J.   +4 more
europepmc   +1 more source

Why Some Patients Undergoing Lipoprotein Apheresis Therapy Develop New Cardiovascular Events? [PDF]

J Cardiovasc Dev Dis, 2020
Julius U, Kuss S, Tselmin S, Schatz U, Bornstein SR.   +4 more
europepmc   +1 more source

Real-World Efficacy of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors (PCSK9i) in Heterozygous Familial Hypercholesterolemia Patients Referred for Lipoprotein Apheresis. [PDF]

Med Sci Monit, 2021
Matta A, Bongard V, Bouisset F, Taraszkiewicz D, Rabès JP, Ferrières J.   +5 more
europepmc   +1 more source

Combined Treatment With Lipoprotein Apheresis and Hemodialysis in Patients With Severe Cardiovascular Disease, High Lipoprotein(a) and End Stage Renal Disease. [PDF]

J Clin Apher
Röseler T, Kayser D, Schlieper G, Bernhardt WM.   +3 more
europepmc   +1 more source

The Impact of Lipoprotein Apheresis on Oxidative Stress Biomarkers and High-Density Lipoprotein Subfractions. [PDF]

Oxid Med Cell Longev, 2020
Mickiewicz A, Kreft E, Kuchta A, Wieczorek E, Marlęga J, Ćwiklińska A, Paprzycka M, Gruchała M, Fijałkowski M, Jankowski M.   +9 more
europepmc   +1 more source